Benzo[c][1,2,5]thiadiazol-4-amine

Catalog No.: 
ACZBJY298
CAS No.: 
767-64-6
Molecular Formula: 
C6H5N3S
Molecular Weight: 
151.19
Benzo[c][1,2,5]thiadiazol-4-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$124.00In stockIn stock
25g98%$507.00In stockIn stock
100g98%$1967.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameBenzo[c][1,2,5]thiadiazol-4-amine
IUPAC Namebenzo[c][1,2,5]thiadiazol-4-amine
MDL No.MFCD00005810
Molecular FormulaC6H5N3S
Molecular Weight151.19
SMILESNC1=CC=CC2=NSN=C12
InChI KeyDRLGIZIAMHIQHL-UHFFFAOYSA-N
Synonym4-Aminopiazthiole | GEO-00070 | HMS2805B22 | WLN: T56 BNSNJ FZ | UNII-N93ZR5H5L1 | 7-Amino-2,3-benzothiadiazole | SR-01000597187-1 | N93ZR5H5L1 | TS-01998 | Benzo[c][1,2,5]thiadiazol-4-amine | BP-11190 | SMR000438262 | 2,1,3-benzothiadiazol-amine | 4-Amin
CAS No.767-64-6
PubChem CID69845

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACZBJY298 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYWNK680 route compound structure diagram
    ACYWNK6806583-06-8In Stock
  2. Then
  3. ACZBJY298 route product structure diagram
    ACZBJY298767-64-6In Stock
Inquiry

2. ACZBJY298 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCLYH540 route compound structure diagram
    ACCLYH54022034-13-5In Stock
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACZBJY298 route product structure diagram
    ACZBJY298767-64-6In Stock
Inquiry

3. ACZBJY298 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZBJY298 route product structure diagram
    ACZBJY298767-64-6In Stock
Inquiry

Comments (0)